Located in Salt Lake City, UT, Dr. Eric Cerrati is proud to introduce DAXXIFY™, an innovative solution that addresses the common desire for longer-lasting frown line treatments. But what exactly is DAXXIFY™, and how does it stand out?

Understanding DAXXIFY™

DAXXIFY™ has earned its FDA approval as a trusted treatment designed to smooth moderate to severe lines, specifically between the brows. Its distinctive feature? DAXXIFY™ incorporates a unique peptide, empowering it to offer results that average between 6 to 9 months for various individuals. This duration is notably extended compared to traditional injectables, which generally require reapplication every 3-4 months. As a result, many patients, approximately 90%, express a desire for more enduring results. With DAXXIFY™, this is made possible, potentially requiring just two treatments within a year to keep those pesky frown lines at bay.

Clinical studies on DAXXIFY™ showcase its effectiveness. At least half of the study participants witnessed minimal or no frown lines 6 months post-treatment. Furthermore, between 5% to 17% of patients observed noticeable improvement even after 9 months.

The Peptide Advantage

All treatments for frown lines need a special ingredient to stabilize the botulinum toxin A, the critical protein tasked with smoothing out those deep-set lines. Common treatments, such as BOTOX® Cosmetic, rely on human serum albumin (HSA), a product derived from blood, to serve this stabilizing role. Another well-known treatment, Dysport®, not only employs HSA as a stabilizer but also uses cow’s milk protein as a protective agent.

Enter DAXXIFY™, the game-changer. It stands alone in its formulation, harnessing the power of an innovative peptide for stabilization. A noteworthy point is that DAXXIFY™ achieves this without incorporating any human or animal byproducts, marking its unique approach in frown line treatments.

DAXXIFY™: Backed by Rigorous Research

DAXXIFY™ isn’t just another name in the cosmetic industry. It’s grounded in robust scientific research. Here are some key insights:

• Extensive Clinical Study: DAXXIFY™ underwent the most comprehensive clinical research for a frown line treatment, engaging more than 2,400 participants spanning varied age groups and skin types.
• Safety Profile: Throughout the clinical trials, there were no significant treatment-related adversities tied to DAXXIFY™.
• Proven Ingredient: Its primary component, botulinum toxin type A, has a track record spanning over two decades in frown line treatments, underscoring its reliability.
• High Satisfaction Rate: An impressive 96% of individuals who opted for DAXXIFY™ were pleased with the outcomes they achieved.

Discover DAXXIFY™ in Salt Lake City

In the landscape of cosmetic enhancements, DAXXIFY™, with its peptide advantage, is setting a new benchmark. Dr. Eric Cerrati, from Salt Lake City, UT, is excited to offer this advanced solution, ensuring that his patients access treatments that align with their goals and deliver lasting results. Contact us today to schedule an appointment!